By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CoDa Therapeutics, Inc. 

San Diego  California    U.S.A.
Phone: Fax:


Start Up

Company News
CoDa Therapeutics, Inc. Announces Positive Results from Phase 2b Study of NEXAGON® in Chronic Venous Leg Ulcers 1/9/2013 9:41:16 AM
CoDa Therapeutics, Inc. Gets $40 Million Series B 7/25/2012 7:38:28 AM
CoDa Therapeutics, Inc., Innate Immunotherapeutics, Mesynthes, Pacific Edge Biotechnology Ltd. (PEB), and PolyBatics Release: New Zealand Life Sciences Innovation Showcased to Health Care Investment and Partnering Community 1/6/2012 6:46:35 AM
Square 1 Announces $6 Million Credit Facility to CoDa Therapeutics, Inc. 10/7/2011 6:31:24 AM
CoDa Therapeutics, Inc. Appoints Chief Medical Officer 5/2/2011 6:49:43 AM
CoDa Therapeutics, Inc. Closes $19 Million Series B Financing Round 4/18/2011 8:47:05 AM
CoDa Therapeutics, Inc.'s NEXAGON(R) Wound Healing Gel Named to Windhover's 'Top 10 HOT SPACE Projects to Watch' 9/17/2010 10:02:42 AM
CoDa Therapeutics, Inc. Achieves Positive Phase 2 Efficacy of NEXAGON(R) in Chronic Venous Leg Ulcers 5/25/2010 8:25:39 AM
New Zealand CoDa Therapeutics, Inc. Raises $29M For Tissue Repair Research 2/21/2007 12:00:46 AM
CoDa Therapeutics, Inc. Announces $10 Million Series A Financing 10/11/2006 9:28:07 AM